- Telehealth visits
Christine Zalecki, PhD, MA
Psychology (Child and Adolescent Psychology)- Telehealth visits
Christine Zalecki, PhD, MA
Psychology (Child and Adolescent Psychology)- Telehealth visits
On this page
About me
Christine Zalecki is a clinical psychologist who specializes in the diagnostic assessment of children with attention-deficit/hyperactivity disorder (ADHD) and learning disorders. She also provides individual and family therapy services for young people with ADHD and other behavioral disorders; her expertise includes psychosocial therapies such as behavior modification techniques. In addition, she leads group training for parents and skills training for children with learning and attention problems, and she provides school consultations.
In her research, Zalecki has studied ADHD and the development life skills programs for children with attention disorders. She directed two studies in these areas funded by the National Institute of Mental Health.
Zalecki earned a doctorate in clinical science at the University of California, Berkeley. She completed a clinical fellowship at UCSF.
Zalecki has published research articles and contributed to books on ADHD. She also speaks regularly at Bay Area schools, information sessions for parents and meetings of mental health professionals.
Education & training
Fellowship
- UCSF School of Medicine -GME
Internship
- UCSF School of Medicine -GME
Degree
- PHD, University of California Berkeley
Academic Title
- Health Sciences Clinical Professor
My expertise
Specialties
Locations
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.